Mark Fleury
Mark Fleury
@mfleury.bsky.social
Research and FDA Policy, Cancer, Public Health, Clinical Trials
We'll only know true impact in a couple of years when we see if these trials were ultimately completed and published. Broader takeaway, however, still stands that trials as well as research broadly (both ongoing and future) have been greatly impacted by this administration's funding cuts 5/5
November 17, 2025 at 8:17 PM
No way to know whether data analysis would continue as planned without parent grant. Would like to see additional analysis to understand if trials changed status to terminated after grant cancellation or if they continued anyway.4/5
November 17, 2025 at 8:17 PM
Reminder that it is wonderful if participants receive benefit from research, but underlying premise of research is that benefit accrues to future patients based on learning, thus potential harm is lost opportunity to gain knowledge as well as ethics of not learning from those who volunteered. 3/5
November 17, 2025 at 8:17 PM
Article states "...more than 74 000 trial participants were affected." but should have said "Terminated grants funded trials in which 74,000 people had taken part." Depending on indiv circumstances-e.g. whether still getting treatment-patients might have not felt any individual impact. 2/5
November 17, 2025 at 8:17 PM
The solution? Spread NCI funding out to more community and rural site to boost infrastructure to conduct research. Read our blog summary of the paper here: www.cambridge.org/core/blog/20...
Assessing Populations with Access to National Cancer Institute-Funded Sites Using Local Distance-based Service Areas « News# « Cambridge Core Blog
Cancer is the second-leading cause of death in the U.S., but thanks in part to research, cancer mortality has dropped by more than a third over the past three decades. That research is founded on will...
www.cambridge.org
October 3, 2025 at 4:16 PM